BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8555066)

  • 1. New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation.
    Meijerink JP; Raemaekers JM; Mensink EJ
    Br J Haematol; 1995 Nov; 91(3):630-9. PubMed ID: 8555066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction.
    Corbally N; Grogan L; Dervan PA; Carney DN
    Br J Cancer; 1992 Nov; 66(5):805-9. PubMed ID: 1419624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
    Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
    Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection.
    Zelenetz AD; Chen TT; Levy R
    J Exp Med; 1992 Oct; 176(4):1137-48. PubMed ID: 1402658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.
    Gauwerky CE; Hoxie J; Nowell PC; Croce CM
    Oncogene; 1988 May; 2(5):431-5. PubMed ID: 3131717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
    Lee JT; Innes DJ; Williams ME
    J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
    Tanaka S; Louie DC; Kant JA; Reed JC
    Blood; 1992 Jan; 79(1):229-37. PubMed ID: 1339299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes.
    Corbally N; Grogan L; Keane MM; Devaney DM; Dervan PA; Carney DN
    Am J Clin Pathol; 1994 Jun; 101(6):756-60. PubMed ID: 8209865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
    LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
    Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens.
    Mitani S; Aoki N; Mizutani S; Fujiwara M; Kitagawa T; Uehara T; Mori S
    Jpn J Cancer Res; 1993 Jan; 84(1):37-41. PubMed ID: 8449825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
    Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
    Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. bcl-2 translocation in Japanese B cell lymphoma: novel bcl-2 translocation with immunoglobulin heavy chain diversity segment.
    Seto M; Osada H; Ueda R; Ito C; Iwaki O; Oyama A; Suchi T; Takahashi T
    Jpn J Cancer Res; 1991 Jan; 82(1):65-71. PubMed ID: 1900270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent.
    Wang J; Raffeld M; Medeiros LJ; Longo DL; Jaffe ES; Duffey P; Stetler-Stevenson M
    Leukemia; 1993 Nov; 7(11):1834-9. PubMed ID: 7694006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression.
    Reed JC; Tanaka S
    Leuk Lymphoma; 1993 Jun; 10(3):157-63. PubMed ID: 8220113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.
    Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Hübner K; Fischer R; Georgii A
    Virchows Arch; 1995; 426(1):37-41. PubMed ID: 7704322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification.
    Hickish TF; Purvies H; Mansi J; Soukop M; Cunningham D
    Br J Cancer; 1991 Dec; 64(6):1161-3. PubMed ID: 1764381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence preservation of the third exon of the bcl-2 gene in non-Hodgkin's lymphoma: absence of somatic hypermutation.
    Farrugia MM; Duan LJ; Reis MD; Ngan BY; Sawka CA; Berinstein NL
    Leukemia; 1995 Apr; 9(4):643-9. PubMed ID: 7723399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.